Detalhe da pesquisa
1.
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.
N Engl J Med
; 360(18): 1839-50, 2009 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19403903
2.
HVR-1 heterogeneity during treatment with telaprevir with or without pegylated interferon alfa-2a.
Scand J Gastroenterol
; 46(11): 1362-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21815864
3.
Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials.
PLoS One
; 7(4): e34372, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22511937
4.
Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus.
Nat Biotechnol
; 29(11): 993-1003, 2011 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22068541
5.
Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients.
Hepatology
; 46(3): 631-9, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17680654
6.
Phenotypic and structural analyses of hepatitis C virus NS3 protease Arg155 variants: sensitivity to telaprevir (VX-950) and interferon alpha.
J Biol Chem
; 282(31): 22619-28, 2007 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-17556358
7.
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir.
Gastroenterology
; 132(5): 1767-77, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17484874